1 / 4

Asia-Pacific Metabolic Disorder Therapeutics Market Size, Share, Analysis, Industry Report and Forecast - 2020-2026

<br>Asia-Pacific metabolic disorder therapeutics market is estimated to grow at a CAGR of 8.2% during the forecast period. The rising prevalence of metabolic disorders and increasing awareness regarding health is driving the demand for metabolic disorder therapeutics in the region. As per the World Bank, in China, the prevalence of diabetes among the population ages 20-79 was 9.2% in 2019. It is growing significantly due to sedentary lifestyle habits. In India, the prevalence of diabetes was found to be 11.8% in people above the age of 50.

pooja99
Download Presentation

Asia-Pacific Metabolic Disorder Therapeutics Market Size, Share, Analysis, Industry Report and Forecast - 2020-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Asia-Pacific Metabolic Disorder Therapeutics Market Size, Share, Analysis, Industry Report and Forecast - 2020-2026 Request a free sample of our report on Asia-Pacific Metabolic Disorder Therapeutics Market: https://www.omrglobal.com/request-sample/asia-pacific-metabolic-disorder- therapeutics-market ------------------------------------------------------------------------------------------------------------------- Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

  2. Asia-Pacific metabolic disorder therapeutics market is estimated to grow at a CAGR of 8.2% during the forecast period. The rising prevalence of metabolic disorders and increasing awareness regarding health is driving the demand for metabolic disorder therapeutics in the region. As per the World Bank, in China, the prevalence of diabetes among the population ages 20-79 was 9.2% in 2019. It is growing significantly due to sedentary lifestyle habits. In India, the prevalence of diabetes was found to be 11.8% in people above the age of 50. Request a free sample of our report on Asia-Pacific Metabolic Disorder Therapeutics Market: https://www.omrglobal.com/request-sample/asia-pacific-metabolic-disorder- therapeutics-market Diabetes disrupts normal metabolism, which results in the demand for medications that are used for the treatment of the condition. These medications include Metformin (Glucophage, Glumetza, others), Thiazolidinediones (rosiglitazone (Avandia), and pioglitazone (Actos)), and others. Rosiglitazone (Avandia) is intended for use as an adjunct to exercise and diet to improve glycemic control in adults suffering from type 2 diabetes mellitus. It is a highly potent and selective agonist for the peroxisome proliferator-activated receptor-gamma (PPAR?)-responsive genes that participate in the regulation of fatty acid metabolism. A full report of Asia-Pacific Metabolic Disorder Therapeutics Market is available at: https://www.omrglobal.com/industry-reports/asia-pacific-metabolic-disorder- therapeutics-market Asia-Pacific Metabolic Disorder Therapeutics Market Segmentation By Therapy •Drug Therapy •Gene Therapy

  3. •Cellular Transplantation •Enzyme Replacement Therapy •Others By Disease •Obesity •Diabetes •Lysosomal Storage Disease •Hypercholesterolemia •Others Regional Analysis •China •India •Japan •Rest of Asia-Pacific Company Profiles •Astellas Pharma, Inc. •Biocon, Ltd. •Cipla, Inc. •Dr. Reddy's Laboratories, Ltd. •Hengrui Therapeutics, Inc. •Lupin, Ltd.

  4. •Shanghai Fosun Pharmaceutical Group (Co.), Ltd. •Shanghai Pharmaceuticals Holding Co., Ltd. •Sun Pharmaceutical Industries, Ltd. •Takeda Pharmaceutical Co., Ltd. For https://www.omrglobal.com/report-customization/asia-pacific-metabolic-disorder- therapeutics-market more customized data, request for report customization @ About us: Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. For More Information, Visit https://www.omrglobal.com/ Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

More Related